5th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 23 - April 1, 2024 - Registraiton for on demand access available until April 1!

On demand registration is open until April 1!

Agenda

Our sponsors:
Titanium
Platinum
Gold
Silver

Building upon the success of prior workshops, the International Myeloma Society is happy to host the 5th Immune Effector Cell Therapies in Multiple Myeloma Workshop to discuss immune-based therapies in myeloma including the latest CAR T cell and bispecific T cell-engager clinical data, promising preclinical leads, updated correlative analyses exploring predictors of response and resistance mechanisms, and next-generation manufacturing and CAR construct approaches, including “off-the-shelf” allogeneic and NK-cell based strategies.

Registration Fees

In Person Registration

  • Admission to scientific sessions.
  • Admission to breakfasts, lunches, and coffee breaks.
  • Certificate of attendance.
  • One-year access to on-demand session recordings. Access instructions will be provided 3 weeks post-event.

 

On-demand Registration

  • One-year access to on-demand session recordings. Access instructions will be provided within 3 weeks post-event.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events